Login
Request Demo
Publications

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)

This paper aimed to describe the persistence of treatment with subcutaneous tumor necrosis factor inhibitors (TNFi) adalimumab, etanercept, and golimumab in immune-mediated rheumatic disease (rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis) by treatment sequence (first-line treatment, second-line or further lines of treatment).

Authors: Mustafa Acar, Prabhjot Juneja, Malcolm Handel

Open Access Rheumatology Research and Reviews https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267492/ | Date: October, 2018

Download document

Download Now
PCIRheumatic diseaseRWDTreatment persistence

Related Resources

Real-world study of the use of azacitidine in myelodysplasia in Australia

Uncovering real-world insights into MDS treatment in Australia: Our study in eJHaem highlights the importance of treatment adherence and the need for innovative solutions.

Real-World Study: Treatment Persistence in Pulmonary Arterial Hypertension Patients

The study analysed real-world data to compare treatment persistence and adherence among PAH patients on ERAs in Japan. Results showed significantly higher persistence with a medication compared to the other two medications.

Persistence and adherence to second-generation antipsychotic long-acting injectable medications for schizophrenia

This study aimed to examine patient characteristics, persistence and adherence to treatment associated with use of second-generation antipsychotic long-acting injectable (SGA LAI) medications in the Australian real-world setting.

Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions

Gout is the most common form of inflammatory arthritis in men. Despite the availability of effective urate-lowering therapies (ULT), the management of gout is suboptimal due to poor persistence with ULT. This study examined national prescribing patterns of ULT to...